Antagonizing CD73 antibody

• 收藏
• 分享

专利权人:

Boehringer Ingelheim International GmbH

发明人:

HOFMANN, Irmgard, Maria Rita,AHLBERG, Jennifer,GANESAN, Rajkumar,GUPTA, Priyanka,MOSTBOECK, Sven,PLYTE, Simon,SCHAAF, Otmar,TSAI, Chia-Hung,WURM, Melanie,ZETTL, Markus,DE ANDRADE PEREIRA, Bruna,BOETTC

申请号：

AU2019274626

公开号：

AU2019274626A1

申请日:

2019.05.13

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present invention relates to novel antagonizing antibodies for CD73. The invention also relates to nucleic acids encoding such antibody molecules； to methods for preparing such antibody molecules； to host cells expressing or capable of expressing such antibody molecules； to compositions comprising such antibody molecules； and to uses of such antibody molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/